News
-
-
PRESS RELEASE
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
mAbxience and Sandoz sign a collaboration agreement to advance biosimilar access worldwide, combining development and commercial expertise to broaden patient access to high-quality biologic medicines -
-
-
-
PRESS RELEASE
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies